PMC:7463108 / 103589-104516 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T31 549-553 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T32 660-670 Body_part denotes G proteins http://purl.org/sig/ont/fma/fma61788
T33 834-844 Body_part denotes G proteins http://purl.org/sig/ont/fma/fma61788

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T33 49-50 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T34 250-259 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T35 531-541 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T36 549-558 http://purl.obolibrary.org/obo/CL_0000000 denotes cell type
T37 577-578 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T38 597-606 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T39 646-656 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T40 774-786 http://purl.obolibrary.org/obo/OBI_0000245 denotes organization
T41 795-804 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T42 860-863 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T43 921-925 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T33804 15-20 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T55394 220-228 Chemical denotes agonists http://purl.obolibrary.org/obo/CHEBI_48705
T93088 416-424 Chemical denotes agonists http://purl.obolibrary.org/obo/CHEBI_48705
T83042 662-670 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T71 836-844 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3544 44-47 Gene denotes MOR Gene:4988
3545 335-338 Gene denotes MOR Gene:4988
3546 342-344 Gene denotes Gα Gene:8802
3547 412-415 Gene denotes MOR Gene:4988
3548 527-530 Gene denotes MOR Gene:4988
3549 690-698 Disease denotes Williams MESH:D018980

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T15 250-259 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T16 597-615 http://purl.obolibrary.org/obo/GO_0007165 denotes signaling pathways
T17 597-606 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T18 795-804 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1305 0-302 Sentence denotes As most opiate drugs preferentially act via MOR, a potential explanation for differential interactive effects of opioids in the context of neuroHIV is the phenomenon of selective or “biased agonism”, such that different agonists can trigger distinct signaling events at the same receptor (Hauser et al.
T1306 303-309 Sentence denotes 2012).
T1307 310-451 Sentence denotes For example, coupling of MOR to Gα, Gβγ, and/or β-arrestin have been noted to differ depending on the MOR agonists involved (McPherson et al.
T1308 452-473 Sentence denotes 2010; Thompson et al.
T1309 474-495 Sentence denotes 2015; Burgueno et al.
T1310 496-502 Sentence denotes 2017).
T1311 503-705 Sentence denotes Physiologic outcomes of MOR activation in any cell type are determined by a bias for specific signaling pathways, the initial step of which is activation of G proteins and/or β-arrestin (Williams et al.
T1312 706-726 Sentence denotes 2013b; Violin et al.
T1313 727-750 Sentence denotes 2014; Suomivuori et al.
T1314 751-757 Sentence denotes 2020).
T1315 758-927 Sentence denotes The subcellular organization of GPCR signaling transduced by heterotrimeric G proteins and β-arrestin has been recently reviewed in detail (Eichel and von Zastrow 2018).

2_test

Id Subject Object Predicate Lexical cue
32876803-22591368-62958367 303-307 22591368 denotes 2012
32876803-20647394-62958368 452-456 20647394 denotes 2010
32876803-24460711-62958369 474-478 24460711 denotes 2015
32876803-24878326-62958370 727-731 24878326 denotes 2014
32876803-32079767-62958371 751-755 32079767 denotes 2020
32876803-29478570-62958372 921-925 29478570 denotes 2018